Anticancer Therapies – News and Features

Company announces financial results and operational highlights.

Scientists have written the 'Book of Cancer Knowledge' to aid future research into drug discovery and personalized medicine.

Institute recommends evaluation and validation process to prevent problems associated with turning 'omics' research into clinical tests.

Cancer Research UK scientists have discovered a promising new approach to treat a type of myeloid leukaemia – a cancer with limited treatment options and relatively poor survival.

Enrolment of patients into trials will begin shortly.

Genomic profile demonstrates high concordance with existing commercial assays and identifies broader range of actionable alterations.

Collaboration to launch novel ex-vivo 3D cell culture system with a focus on oncology applications.

Rosetta Genomics, Ltd. announced the study has been published in the online edition of the International Journal of Oncology and is expected to appear in the upcoming print edition.

Immunovative Therapies, Ltd. has retained the services of Andra E. Miller, Ph.D. and Holly M. Scott of Biologics Consulting Group, Inc. to provide Immunovative with in-depth assistance and compliance with U.S. Food FDA regulations and requirements with respect to GCP and GMP.

UK-based CDMO invests over £500k in new vial filling equipment.